Channelopathy: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Ion_channel_image_-_Kim_2014_PMCID_3935107.png | |||
</gallery> | |||
Revision as of 22:04, 16 February 2025
Channelopathy is a term that refers to diseases caused by disturbed function of ion channel subunits or the proteins that regulate them. These diseases may be either congenital (present at birth) or acquired. Channelopathies are known to affect a variety of body systems, and can result in symptoms ranging from mild to severe.
Types of Channelopathies
Channelopathies can be broadly classified into the following categories:
- Neurological Channelopathies: These include diseases such as Epilepsy, Migraine, Ataxia, and Paralysis.
- Cardiac Channelopathies: These include conditions such as Long QT Syndrome, Short QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
- Endocrine Channelopathies: These include diseases such as Familial Hyperinsulinemic Hypoglycemia and Thyrotoxic Hypokalemic Periodic Paralysis.
Causes of Channelopathies
Channelopathies are usually caused by mutations in the genes that encode ion channels. These mutations can either be inherited or occur spontaneously. In some cases, channelopathies can also be acquired as a result of autoimmune diseases or the use of certain medications.
Diagnosis and Treatment
The diagnosis of channelopathies often involves genetic testing, as well as tests to assess the function of the affected body system. Treatment typically involves managing the symptoms and preventing complications. This may include medication, lifestyle changes, and in some cases, surgery.


